Globus Medical INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Globus Medical achieved significant revenue and net income growth in 2025, driven by strategic acquisitions and new product launches, despite ongoing legal and regulatory challenges.
NYSE
Globus Medical's 2024 10-K filing highlights a year of significant growth and strategic integration following the NuVasive merger, alongside ongoing efforts to innovate and expand its market presence.
NYSE
Globus Medical, Inc.'s 10-K filing outlines its share structure, voting rights, dividend policies, and compliance with SEC regulations, including details on its dual-class common stock and anti-takeover provisions.